CEN BIOTECH INC Contracts & Agreements
75 Contracts & Agreements
- Business Finance (43 contracts)
- Business Operations (9)
- Human Resources (13)
- Mergers & Acquisitions (3)
- Real Estate (2)
- Uncategorized (5)
- Termination and Release Agreement, dated March 23, 2023 (Filed With SEC on March 29, 2023)
- Executive Employment Agreement between CEN Biotech, Inc. and Lawrence Lehoux dated August 26, 2022 (Filed With SEC on August 31, 2022)
- Executive Employment Agreement between CEN Biotech, Inc. and Brian S. Payne dated August 26, 2022 (Filed With SEC on August 31, 2022)
- Restricted Stock Agreement between CEN Biotech, Inc. and Lawrence Lehoux dated August 29, 2022 (Filed With SEC on August 31, 2022)
- Restricted Stock Agreement between CEN Biotech, Inc. and Brian S. Payne dated August 29, 2022 (Filed With SEC on August 31, 2022)
- Restricted Stock Agreement between CEN Biotech, Inc. and Donald Strilchuck dated August 29, 2022 (Filed With SEC on August 31, 2022)
- Restricted Stock Agreement between CEN Biotech, Inc. and George Dragicevic dated August 29, 2022 (Filed With SEC on August 31, 2022)
- Restricted Stock Agreement between CEN Biotech, Inc. and Harold Andre Aubrey de Lavenu dated August 29, 2022 (Filed With SEC on August 31, 2022)
- Restricted Stock Agreement between CEN Biotech, Inc. and Jeffrey Thomas dated August 29, 2022 (Filed With SEC on August 31, 2022)
- Restricted Stock Agreement between CEN Biotech, Inc. and Josef Tukacs dated August 29, 2022 (Filed With SEC on August 31, 2022)
- Amendment to No. 1 to Patent Purchase and Assignment Agreement dated July 14, 2022 by and between the Company and Emergence Global Enterprises Inc (Filed With SEC on July 20, 2022)
- Termination of Patent Purchase and Assignment Agreement dated July 19, 2022 by and between the Company and Emergence Global Enterprises Inc (Filed With SEC on July 20, 2022)
- Form of Securities Purchase Agreement with 1800 Diagonal Lending LLC dated May 24, 2022 (Filed With SEC on May 27, 2022)
- Form of Convertible Promissory Note issued to 1800 Diagonal Lending LLC dated May 24, 2022 (Filed With SEC on May 27, 2022)
- Form of Patent Purchase and Assignment Agreement withEmergence Global Enterprises Inc. dated May 24, 2022 (Filed With SEC on May 26, 2022)
- Form of Patent Assignment Agreement with Emergence Global Enterprises Inc. dated May 24, 2022 (Filed With SEC on May 26, 2022)
- Settlement Agreement dated April 19, 2022 between the registrant and Bahige (Bill) Chaaban (Filed With SEC on April 21, 2022)
- Settlement Agreement dated April 19, 2022 between the registrant and Alex Tarrabain (Filed With SEC on April 21, 2022)
- Settlement Agreement dated April 19, 2022 between the registrant and Rick Purdy (Filed With SEC on April 21, 2022)
- Settlement Agreement dated April 19, 2022 between the registrant and Ameen Ferris (Filed With SEC on April 21, 2022)
- Settlement Agreement dated April 19, 2022 between the registrant and Richard Boswell (Filed With SEC on April 21, 2022)
- Description of Capital Stock of Cen Biotech, Inc (Filed With SEC on April 14, 2022)
- Executive Employment Agreement between CEN Biotech, Inc. and Rick Purdy, dated December 6, 2021 (Filed With SEC on December 8, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Rick Purdy, dated December 6, 2021 (Filed With SEC on December 8, 2021)
- Asset Purchase and Sale Agreement, dated as of October 7, 2021 (Filed With SEC on October 13, 2021)
- Patent Assignment, dated October 7, 2021 (Filed With SEC on October 13, 2021)
- Bill of Sale, dated October 7, 2021 (Filed With SEC on October 13, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Patrick Carl Keane (Filed With SEC on July 16, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Daniel William Scott (Filed With SEC on July 16, 2021)
- Employment Agreement with Lawrence Lehoux dated July 9, 2021 (Filed With SEC on July 13, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Alex Tarrabain (Filed With SEC on June 25, 2021)
- Share Exchange between CEN Biotech, Inc. and Clear Com Media Inc., an Ontario, Canada corporation (CCM), the shareholders of CCM and Lawrence Lehoux as the Representative of the... (Filed With SEC on April 20, 2021)
- Business Coaching Contract between CEN Biotech, Inc. and CONFIEN SAS dated April 2, 2021 (Filed With SEC on April 8, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and CONFIEN SAS dated April 2, 2021 (Filed With SEC on April 8, 2021)
- CEN Biotech, Inc. 2021 Equity Compensation Plan (Filed With SEC on April 7, 2021)
- Form of Restricted Stock Agreement for U.S. persons under 2021 CEN Biotech, Inc. Equity Compensation Plan (Filed With SEC on April 7, 2021)
- Form of Restricted Stock Agreement for Canadian persons under 2021 CEN Biotech, Inc. Equity Compensation Plan (Filed With SEC on April 7, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Richard Boswell (Filed With SEC on April 7, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Bahige Chaaban (Filed With SEC on April 7, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Ameen Ferris (Filed With SEC on April 7, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Harold D. Lavenu (Filed With SEC on April 7, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Brian Payne (Filed With SEC on April 7, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Usamakh Saadikh (Filed With SEC on April 7, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Donald Strilchuck (Filed With SEC on April 7, 2021)
- Restricted Stock Agreement between CEN Biotech, Inc. and Alex Tarrabain (Filed With SEC on April 7, 2021)
- Executive Employment Agreement between CEN Biotech, Inc. and Ameen Ferris (Filed With SEC on April 7, 2021)
- Executive Employment Agreement between CEN Biotech, Inc. and Harold Aubrey De Lavenu (Filed With SEC on April 7, 2021)
- Termination and Release Agreement dated May 19, 2020 (Filed With SEC on May 20, 2020)
- Termination and Release Agreement dated May 19, 2020 (Filed With SEC on May 20, 2020)
- Amendment dated March 16, 2020, to Share Purchase Agreement dated August 31, 2016, and executed September 12, 2016, as amended, between CEN Biotech, Inc. and Stevan Pokrajac and... (Filed With SEC on March 17, 2020)
- Amendment No. 1 to Merger Agreement, dated August 27, 2019, by and between CEN Biotech, Inc. and Caduceus Software Systems Corp. and Caduceus Merger Sub, Inc (Filed With SEC on August 29, 2019)
- Amendment No. 2 to Merger Agreement, dated August 28, 2019, by and between CEN Biotech, Inc. and Caduceus Software Systems Corp. and Caduceus Merger Sub, Inc (Filed With SEC on August 29, 2019)
- Form of Merger Agreement dated June 21, 2019, between CEN Biotech, Inc. and Caduceus Software Systems Corp. and Caduceus Merger Sub, Inc (Filed With SEC on June 21, 2019)
- Executive Employment Agreement dated May 16, 2019, between CEN Biotech, Inc. and Alex Tarrabain (Filed With SEC on May 16, 2019)
- Restricted Stock Agreement dated May 16, 2019, between CEN Biotech, Inc. and Alex Tarrabain (Filed With SEC on May 16, 2019)
- Term Sheet dated May 15, 2019, between CEN Biotech, Inc. and Caduceus Software Systems Corp (Filed With SEC on May 16, 2019)
- Share Purchase Agreement dated August 31, 2016, and executed September 12, 2016, between CEN Biotech, Inc. and Stevan Pokrajac and Tesla Digital Inc. and Tesla Digital Global... (Filed With SEC on April 16, 2019)
- Amendment dated March 29, 2018 to Share Purchase Agreement dated August 31, 2016, and executed September 12, 2016, between CEN Biotech, Inc. and Stevan Pokrajac and Tesla Digital... (Filed With SEC on April 16, 2019)
- Agreement for use of patent between CEN Biotech, Inc. and Stevan Pokrajac and Tesla Digital Inc. and Tesla Digital Global Group Inc., dated .April 15, 2019 (Filed With SEC on April 16, 2019)
- Amendment dated April 3, 2019, to Share Purchase Agreement dated August 31, 2016, and executed September 12, 2016, as amended, between CEN Biotech, Inc. and Stevan Pokrajac and... (Filed With SEC on April 8, 2019)
- Share Repurchase Agreement, executed as of November 27, 2017, by and between James L. Robinson and CEN Biotech Inc (Filed With SEC on November 30, 2018)
- Amending Agreement dated October 4, 2018 (Filed With SEC on October 9, 2018)
- Share Purchase Agreement, dated as of July 31, 2018 (Filed With SEC on August 6, 2018)
- Commercial Lease Agreement, dated January 1, 2017, between Jamaal Shaban and Cen Biotech,Inc (Filed With SEC on April 16, 2018)
- Agreement to Lease, dated October 1, 2017 between R&D Labs Canada Inc. and CEN Biotech Inc (Filed With SEC on April 16, 2018)
- Mutual Consent to Terminate Agreement, dated September 1, 2013 between Jamaal Jime Shaban and CEN Biotech Inc (Filed With SEC on April 16, 2018)
- Controlling Interest Purchase Agreement, dated as of December 14, 2017 (Filed With SEC on December 14, 2017)
- Share Repurchase Agreement, dated as of December 11, 2017 (Filed With SEC on December 12, 2017)
- Executive Employment Agreement of Bahige (Bill) Chaaban and Cen Biotech Inc (Filed With SEC on December 5, 2017)
- Executive Employment Agreement of Joseph Byrne and Cen Biotech Inc (Filed With SEC on December 5, 2017)
- Executive Employment Agreement of Richard Boswell and Cen Biotech Inc (Filed With SEC on December 5, 2017)
- Executive Employment Agreement of Brian Payne and Cen Biotech Inc (Filed With SEC on December 5, 2017)
- 2017 Equity Compensation Plan (Filed With SEC on December 5, 2017)
- Form of Restricted Stock Agreement for US Persons (Filed With SEC on December 5, 2017)
- Form of Restricted Stock Agreement for Canadian Persons (Filed With SEC on December 5, 2017)
